MERS Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Study of Safety and Immunogenicity of BVRS-GamVac
Conditions:   MERS (Middle East Respiratory Syndrome);   MERS Interventions:   Biological: BVRS-GamVac;   Other: placebo Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2019 Category: Research Source Type: clinical trials

Study of Safety and Immunogenicity of BVRS-GamVac-Combi
Conditions:   MERS (Middle East Respiratory Syndrome);   MERS Interventions:   Drug: BVRS-GamVac-Combi;   Other: placebo Sponsors:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation;   Acellena Contract Drug Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials